生命科学资讯
生物技术与制药领域的最新动态
Illumina, Inc. $ILMN Shares Sold by Mitsubishi UFJ Trust & Banking Corp - MarketBeat
Thermo Fisher Scientific (TMO)的定价是否反映了近期稳健的回报与增长预期 - simplywall.st
Is Thermo Fisher Scientific (TMO) Pricing Reflecting Recent Steady Returns And Growth Expectations - simplywall.st
Roche announces positive phase II results for experimental obesity drug - wkzo.com
康帕斯财富管理有限责任公司购入16,124股赛默飞世尔科技公司股票 $TMO - MarketBeat
Compass Wealth Management LLC Buys 16,124 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
单细胞基因组测序市场即将迎来繁荣 |• 10x Genomics • Illumina - openPR.com
Single-Cell Genome Sequencing Market Is Going to Boom |• 10x Genomics • Illumina - openPR.com
英美生物科技投资公司Epidarex为其第四只基金筹集1.45亿美元
UK-US biotech investor Epidarex raises $145M for fourth fund
分析师观点：15位专家眼中的Illumina - Benzinga
The Analyst Verdict: Illumina In The Eyes Of 15 Experts - Benzinga
IRA药品定价请愿书在最高法院堆积如山。
IRA drug pricing petitions pile up at the Supreme Court
临床雄心：10x Genomics通过三项合作拓展至研究之外——GEN《基因工程与生物技术新闻》
Clinical Ambitions: 10x Expands Beyond Research with Trio of Collaborations - GEN - Genetic Engineering and Biotechnology News
前CytoDyn首席执行官被判入狱，需支付530万美元赔偿，而前CRO负责人赢得新审判。
Ex-CytoDyn CEO sentenced to prison, must pay $5.3M restitution as former CRO leader wins new trial
欧洲投资公司Gimv宣布停止新的生命科学融资业务。
European investment firm Gimv calls it quits on new life science financing
新规之下，风险加剧：生物制药行业押注2026年长远布局
New rules, higher stakes: Biopharma plays the long game in 2026
PitchBook称中国在早期药物研发领域的优势“可能持续”。
China’s edge in early-stage drugmaking ‘likely to persist,’ Pitchbook says
前CytoDyn首席执行官因“拉高出货”欺诈案被判30个月监禁。
Ex-CytoDyn CEO sentenced to 30 months for pump-and-dump scheme
2026年1月19日至23日医疗科技股涨跌榜
Med-tech gainers and losers for Jan. 19-23, 2026
Catalent计划关闭比利时细胞疗法生产基地
Catalent plans to close Belgium cell therapy site
2026年1月26日融资动态
Financings for Jan. 26, 2026
2026年1月26日诊所记录
In the clinic for Jan. 26, 2026
2026年1月26日其他值得关注的新闻
Other news to note for Jan. 26, 2026